CPG for un-cleared medicines focuses on safety risks, lack of effectiveness, fraud.WASHINGTON -- Center for Drugs' Marketed Unapproved un·ap·proved adj. Not approved or sanctioned: an unapproved vaccine; an unapproved protest march. Drugs compliance policy guide (CPG CPG central pattern generators. ) that was introduced in June 2006 focuses on drugs that have safety risks, lack evidence of effectiveness, are fraudulent, directly compete with an approved drug, or have formulation changes made as a pretext to avoid enforcement, stated the director of the Center's Office of Compliance at CDER CDER Center for Drug Evaluation and Research (US FDA) CDER Centre de Développement des Energies Renouvelables (French) CDER Client Development and Evaluation Report Deborah Autor, who spoke here Feb. 20 at FDLI's Feb. 19-20 meeting on enforcement and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. , said that thousands of prescription drugs are marketed without approval and account for about two percent of the 3.6 billion prescriptions filled in the U.S. annually. Autor said that legal categories of marketed unapproved drugs include: * Drug Efficacy Study Implementation Drug Efficacy Study Implementation (DESI) was a program begun by the Food and Drug Administration (FDA) in the 1960s after the requirement that all drugs be efficacious as well as safe. (DESI)--drugs that were the subject of 1938-1962 NDAs . Not grandfathered. They are new drugs and must eventually obtain FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval. * Prescription Wrap-up--drugs that are on the market based on a claim of being a pre-'38 or pre-'62 product. * Post '62 Drugs--Initially marketed after 1962. She stressed that all drugs must have FDA approval or comply with an OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). drug monograph, unless: * DESI Pending--fewer than 20 out of almost 600 currently. * OTC Drug Monograph Pending. * GRAS/E (generally recognized as safe and effective Generally recognized as safe and effective or GRAS/E is a legal term used to describe certain old drugs that do not require prior approval from the Food and Drug Administration in order to enter the United States marketplace because they are generally recognized as safe and )--requires a consensus among expert that the product is safe/effective based on published scientific literature. The exception is for drugs that are grandfathered. Autor stated: "A firm must document that its product is identical in formulation, strength, dosage form, route of administration, indications, intended patient population and other conditions of use to a drug marketed on the relevant date." Some unapproved drugs are known as "legacy drugs," but she quoted Commissioner Andrew von Eschenbach, M.D., who warned in 2007: "Some refer to unapproved marketed drugs as 'legacy drugs.' A legacy is not a substitute for drug approval. Individual experience, anecdotal evidence and marketing history are insufficient bases for concluding that a drug is safe and effective. In fact, experience demonstrates that unapproved drugs often are unsafe, ineffective, inappropriately labeled and poorly manufactured." She said that FDA is working to increase awareness and understanding about unapproved drugs. This includes promoting voluntary compliance and enhancement of understanding and interest in the approval process. The agency also has appointed an unapproved drugs coordinator, and held an unapproved drugs workshop in January 2007, which had more than 400 attendees and resulted in 32 INDs and five NDAs being filed. Joseph Pickett Managing Editor |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion